1531-8257/asset/MDS_left.gif?v=1&s=a99f3b698e6ae32e96dbc75c912d289e5c35649d)
1531-8257/asset/MDS_right.gif?v=1&s=4d3c8316b533aa4e41b7101a2d6fa6f082cf2505)
DA agonists - Ergot derivaties: Dihydroergocryptine (DHEC)
Article first published online: 29 JUL 2002
DOI: 10.1002/mds.5564
Copyright © 2002 Movement Disorders Society
Issue
1531-8257/asset/cover.gif?v=1&s=cbca75ec4eec6abb5c8560896c83f19bae8de2b1 "Movement Disorders")
Movement Disorders
Supplement: Management of Parkinson's Disease: An Evidence-Based Review
Volume 17, Issue Supplement 4, pages S72–S73, July/August 2002
Additional Information
How to Cite
(2002), DA agonists - Ergot derivaties: Dihydroergocryptine (DHEC). Mov. Disord., 17: S72–S73. doi: 10.1002/mds.5564
Publication History
- Issue published online: 29 JUL 2002
- Article first published online: 29 JUL 2002